A Comprehensive Prospective Assessment of the Physical and Biological Effects of Upper Tract Urothelial Cancer (UTUC)

Launched by CHINESE UNIVERSITY OF HONG KONG · Jun 29, 2022

Keywords

ClinConnect Summary

This clinical trial is studying Upper Tract Urothelial Cancer (UTUC), which is a type of cancer that affects the lining of the urinary system. The goal of the study is to gather detailed information about how this cancer impacts patients physically and biologically. By setting up a registry, the researchers hope to better understand the disease and improve treatment options for future patients.

To participate in this trial, you need to be a male over 18 years old who has been diagnosed with UTUC and is awaiting surgery, or you should have a history of UTUC with some previous treatment. If you choose to participate, you can expect to undergo assessments that will help capture important data about your condition. It's important to note that you must be able to provide informed consent to join the study. This trial is currently recruiting participants, and everyone, regardless of age or gender, is welcome to learn more about participating.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male patients \> 18 years old
• • Patients who has presence of UTUC and pending for surgery
• • Patients who has history of UTUC with any intervention performed
• Exclusion Criteria:
• • - Patients fail to provide informed consent